Skip to content

Trial to evaluate the administration of IDOR-1134-2831 vaccine in healthy participants

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-506407-26-00
Acronym
ID-090-101
Enrollment
60
Registered
2024-04-16
Start date
2024-05-28
Completion date
Unknown
Last updated
2025-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clostridioides difficile (C. difficile)

Interventions

None listed

Sponsors

Idorsia Pharmaceuticals Ltd.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026